The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Cardioselective beta-blockers for chronic obstructive pulmonary disease
Open accessAbstract
BACKGROUND: Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative period. These drugs have traditionally been considered contraindicated in patients with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To assess the effect of cardioselective beta-blockers on respiratory function of patients with COPD. SEARCH STRATEGY: A comprehensive search of the Cochrane Airways Group Specialised Register (derived from systematic searches of CENTRAL, MEDLINE, EMBASE and CINAHL) was carried out to identify randomised blinded controlled trials from 1966 to May 2005. We did not exclude trials on the basis of language. SELECTION CRITERIA: Randomised, blinded, controlled trials of single dose or longer duration that studied the effects of cardioselective beta-blockers on the forced expiratory volume in 1 second (FEV1) or symptoms in patients with COPD. DATA COLLECTION AND ANALYSIS: Two independent reviewers extracted data from the selected articles, reconciling differences by consensus. Two interventions studied were the administration of beta-blocker, given either as a single dose or for longer duration, and the use of beta2-agonist given after the study drug. MAIN RESULTS: Eleven studies of single-dose treatment and 9 of treatment for longer durations, ranging from 2 days to 12 weeks, met selection criteria. Cardioselective beta-blockers, given as a single dose or for longer duration, produced no change in FEV1 or respiratory symptoms compared to placebo, and did not affect the FEV1 treatment response to beta2-agonists. A subgroup analysis revealed no change in results for those participants with severe chronic airways obstruction or for those with a reversible obstructive component. AUTHORS' CONCLUSIONS: Cardioselective beta-blockers, given to patients with COPD in the identified studies did not produce adverse respiratory effects. Given their demonstrated benefit in conditions such as heart failure, coronary artery disease and hypertension, cardioselective beta-blockers should not be routinely withheld from patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Celli, B. R., Snider, G. L., Heffner, J. E., Tiep, B. L., Ziment, I., Make, B. J., Braman, S. S., Olsen, G. N., & D, Y. Y. P. M. (1995) · Cited by 3,506
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
Mangano, D. T., Layug, E. L., Wallace, A., & Tateo, I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352301 · Cited by 1,694
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
(1995) · PubMed · Cited by 1,323
Gottlieb, S. S., McCarter, R. J., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 982
Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., Grazi, M., Veglia, F., & Bartorelli, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.043 · Cited by 737
Lechat, P., Packer, M., Chalon, S., Cucherat, M., Arab, T., & Boissel, J.-P. (1998) · Circulation · doi:10.1161/01.cir.98.12.1184 · Cited by 563
Krumholz, H. M., Radford, M. J., Wang, Y., Chen, J., Heiat, A., & Marciniak, T. A. (1998) · JAMA · doi:10.1001/jama.280.7.623 · Cited by 494
Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
Soumerai, S. B. (1997) · JAMA · doi:10.1001/jama.277.2.115 · Cited by 486
A comparison of statistical methods for combining event rates from clinical trials
Berlin, J. A., Laird, N. M., Sacks, H. S., & Chalmers, T. C. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080202 · Cited by 420
Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina
Heidenreich, P. A. (1999) · JAMA · doi:10.1001/jama.281.20.1927 · Cited by 355
Radack, K. L. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.9.1769 · Cited by 336
Rutten, F. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.112 · Cited by 307
Diabetic patients and beta-blockers after acute myocardial infarction
KJEKSHUS, J., GILPIN, E., CALI, G., BLACKEY, A. R., HENNINGJ, H., & ROSS, J. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059591 · Cited by 236
Doughty, R. N., Rodgers, A., Sharpe, N., & MacMahon, S. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015297 · Cited by 230
β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction
Koch-Weser, J., Frishman, W. H., Furberg, C. D., & Friedewald, W. T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101306 · Cited by 211
Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Dransfield, M. T., Rowe, S. M., Johnson, J. E., Bailey, W. C., & Gerald, L. B. (2008) · Thorax · doi:10.1136/thx.2007.081893 · Cited by 209
Bronchial Response to Beta-Adrenergic Blockade
Zaid, G., & Beall, G. N. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609152751103 · Cited by 202
Chen, J., Radford, M. J., Wang, Y., Marciniak, T. A., & Krumholz, H. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01225-6 · Cited by 187
Steinbeck, G., Andresen, D., Bach, P., Haberl, R., Oeff, M., Hoffmann, E., & von Leitner, E.-R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210013271404 · Cited by 185
Jonas, M., Reicher-Reiss, H., Boyko, V., Shotan, A., Mandelzweig, L., Goldbourt, U., & Behar, S. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00191-9 · Cited by 164
Pooling Research Results: Benefits and Limitations of Meta-Analysis
Ioannidis, J. P. A., & Lau, J. (1999) · The Joint Commission Journal on Quality Improvement · doi:10.1016/s1070-3241(16)30460-6 · Cited by 158
van Gestel, Y. R. B. M., Hoeks, S. E., Sin, D. D., Welten, G. M. J. M., Schouten, O., Witteveen, H. J., Şimşek, C., Stam, H. J., Mertens, F. W., Bax, J. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-384oc · Cited by 157
Jabbour, A., Macdonald, P. S., KEOGH, A. M., Kotlyar, E., Mellemkjær, S., Coleman, C. F., Elsik, M., Krum, H., & Hayward, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.024 · Cited by 155
Wadworth, A. N., Murdoch, D., & Brogden, R. N. (1991) · Drugs · doi:10.2165/00003495-199142030-00007 · Cited by 148
Egred, M., Shaw, S. M., Mohammad, B., Waitt, P. I., & Rodrigues, E. (2005) · QJM · doi:10.1093/qjmed/hci080 · Cited by 129
Quality of Life in Treatment of Hypertension: A Metaanalysis of Clinical Trials
Beto, J. A., & Bansal, V. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.3.125 · Cited by 127
Treatment of Hyperthyroid Disease
Klein, I., Becker, D. V., & Levey, G. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00010 · Cited by 120
Cardioselective beta-blockers for reversible airway disease
Salpeter, S. R., Ormiston, T. M., Salpeter, E. E., & Wood-Baker, R. R. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002992 · Cited by 116
Self-citationA meta-analysis of perioperative beta blockade: What is the actual risk reduction?
McGory, M. L., Maggard, M. A., & Ko, C. Y. (2005) · Surgery · doi:10.1016/j.surg.2005.03.022 · Cited by 109
Beta-blockers and depression. Evidence against an association
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.267.13.1783 · Cited by 103
Hawkins, N. M., MacDonald, M. R., Petrie, M. C., Chalmers, G. W., Carter, R., Dunn, F. G., & McMurray, J. J. V. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp066 · Cited by 101
Early β-Blocker Therapy for Acute Myocardial Infarction in Elderly Patients
Krumholz, H. M., Radford, M. J., Wang, Y., Chen, J., & Marciniak, T. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00003 · Cited by 100
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.1992.03480130099032 · Cited by 72
National Patterns and Predictors of β-Blocker Use in Patients With Coronary Artery Disease
Wang, T. J., & Stafford, R. S. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1901 · Cited by 68
Clinical Relevance of Pharmacokinetic Differences Between Beta Blockers
Kendall, M. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00833-3 · Cited by 63
Wellstein, A., Palm, D., Belz, G. G., et al. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_m.3 · Cited by 62
Physician use of beta-adrenergic blocking therapy: a changing perspective
Kennedy, H. L., & Rosenson, R. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80035-f · Cited by 55
Effect of Beta-Blocker Therapy on Functional Status in Patients with Heart Failure — A Meta-Analysis
Abdulla, J., Køber, L., Christensen, E., & Torp-Pedersen, C. T. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.012 · Cited by 53
Viskin, S., & Barron, H. V. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00428-6 · Cited by 49
Sial, S. H., Malone, M., Freeman, J. L., Battiola, R. J., Nachodsky, J. P., & Goodwin, J. S. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02600301 · Cited by 42
Chang, C. L., Mills, G., McLachlan, J. D., Karalus, N., & Hancox, R. J. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01943.x · Cited by 40
Heller, D. A., Ahern, F. M., & Kozak, M. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109650 · Cited by 35
Respiratory function in the elderly and the effects of beta blockade
Tattersfield, A. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00114225 · Cited by 33
Effects of beta-blocking agents on insulin secretion and glucose disposal.
WICKLMAYR, M., Kristian, R. E. T. T., Dietze, G., & Mehnert, H. (1990) · PubMed · Cited by 32
THE EFFECT OF OXPRENOLOL, ACEBUTOLOL AND PROPRANOLOL ON THYROID HORMONES IN HYPERTHYROID SUBJECTS
Jones, M. K., John, R., & JONES, G. R. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03394.x · Cited by 28
Nishikawa, T., Yoshida, A., Tamura, Y., & Yoshida, S. (1990) · Hormone and Metabolic Research · doi:10.1055/s-2007-1004842 · Cited by 25
Hülsmann, M., Sturm, B., Pacher, R., Berger, R., Bojic, A., Frey, B., & Stanek, B. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00341-2 · Cited by 14
Newer beta blockers and the treatment of hypertension
McAreavey, D., Vermeulen, R., & Robertson, J. I. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029727 · Cited by 11
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Panchal, A. R., Bartos, J. A., Cabañas, J. G., Donnino, M. W., Drennan, I. R., Hirsch, K. G., Kudenchuk, P. J., Kurz, M. C., Lavonas, E. J., Morley, P. T., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000916 · Cited by 2,105
Metadata
- Authors
- Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2005-10-19
- Volume
- 2016
- Issue
- 8
- Pages
- CD003566-CD003566
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1960263711
- Cited by
- 381
- References
- 54
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.